Credit Suisse Reiterates Neutral Rating on Genmab A/S (GEN:DC) (GMAB)
Tweet
Share
E-mailCredit Suisse analyst Trung Huynh reiterated a Neutral rating and DKK2,235.00 price target on Genmab A/S (GEN:DC) (NASDAQ: GMAB).
You May Also Be Interested In
- Standard Life Aberdeen Plc. (SLA:LN) (SLFPY) PT Raised to GBP3.76 at Goldman Sachs
- Ashmore Group (ASHM:LN) (AJMPF) PT Lowered to GBP4.60 at Goldman Sachs
- Enerplus Corp. (ERF:CN) (ERF) PT Raised to Cdn$7.50 at Scotiabank
Create E-mail Alert Related Categories
Intl RatingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
